Haemonetics combines Plasma and Blood Center segments into Apheresis; Hospital renamed MedSurg

HAEMONETICS CORP

The new Apheresis segment combines formerly separate Plasma and Blood Center segments, effective Q1 FY2027.
Hospital segment renamed MedSurg to better reflect underlying businesses, technologies, and markets.
Supplemental presentation includes historical quarterly reconciliations from Q1 FY2024 to Q4 FY2026.
FY2027 guidance recast under new segment structure; company not reaffirming or updating guidance.
Updates, if any, to be provided on Q1 FY2027 earnings call.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.